COMP <GO>
FCX vs LIN // REVENUE GROWTH (YOY)
Freeport-McMoRan Inc. (NYSE) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: FCX 4
— LIN 10
▲ REVENUE GROWTH (YOY) LEADER: LIN
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
revenue-growth
0.10%
LAST: $514.24 (+2.20%) • MKT CAP: $231.94B
revenue-growth
3.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FCX VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FCX | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.10% | 41.00% | -14.90 | LIN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.50% | 13.10% | +8.40 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.4x | 18.5x | -5.10 | FCX | /valuation <GO> |
| Free Cash Flow Yield | 4.71% | 2.19% | +2.52 | FCX | /fcf-yield <GO> |
| Operating Margin | 25.90% | 26.30% | -0.40 | LIN | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 20.30% | -11.50 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 0.10% | 3.00% | -2.90 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.91% | 1.21% | -0.30 | LIN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.08 | 3.93 | -0.85 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.90% | -0.20 | FCX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.2 | 69.3 | -39.09 | LIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 1.01 | -0.06 | LIN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.1x | 31.2x | +8.90 | LIN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $94.98B | $231.94B | -$136.96B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FCX REV | LIN REV | FCX GROSS % | LIN GROSS % | FCX FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $25.19B | $33.99B | 26.1% | 44.0% | $4.48B | $5.09B |
| FY 2024 | $25.17B | $33.01B | 29.3% | 44.0% | $6.03B | $4.93B |
| FY 2023 | $22.70B | $32.85B | 44.0% | 44.0% | $4.26B | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FCX // BETA 0.95
LIN // BETA 1.01